SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Mersana Therapeutics, Inc. Presents Data Demonstrating XMT-1001 Substantially Accumulates in Tumor and Results in Significantly Prolonged Drug Exposure